
华盛顿 - 美国总统唐纳德·特朗普与第一夫人梅拉尼娅·特朗普于10月19日共同签署了一项行政命令,成立白宫工作组和国家卫生研究院(NIH)专注于妇女健康的部门。
WASHINGTON - US President Donald Trump signed an executive order alongside first lady Melania Trump on Oct 19 creating a White House task force and a National Institutes of Health division focused on women’s health.
特朗普在白宫活动上表示,该工作组将由白宫幕僚长苏西·怀尔斯领导,她最近宣布自己已愈癌,以及卫生部长罗伯特·F·肯尼迪 Jr。
The task force will be led by White House chief of staff Susie Wiles, who recently announced that she is cancer-free, and Health Secretary Robert F. Kennedy Jr, Trump said at a White House event.
根据白宫发布的事实资料,该命令指示联邦政府在女性健康的全生命周期范围内采取综合方法,加强研究以加快预防、诊断和治疗,并将这些发现转化为临床实践和政策。
It directs the federal government to pursue a comprehensive approach to women’s health across all life stages, strengthening research to speed up prevention, diagnosis, and treatment and translating those findings into clinical practice and policy, according to a White House fact sheet.
特朗普表示,该工作组将于10月19日举行首次会议,他指出这一天正值乳腺癌宣传月。怀尔斯最近刚完成乳腺癌治疗。
The task force will hold its first meeting on Oct 19, Trump said, during what he noted was Breast Cancer Awareness Month. Wiles recently finished treatment for breast cancer.
特朗普在活动上说:“我一会儿就要签署的行政命令将指示卫生与公众服务部在国家卫生研究院内成立一个新的妇女健康部门。”
“The executive order I’ll just a moment will direct the Department of Health and Human Services to establish a new women’s health division within the National Institute of Health,” Trump said at the event.
他说:“这是一件大事。他们一直在为此努力很长时间了。‘谁他妈的不会想要一个妇女健康部门?’梅拉尼娅说他们没有。”NIH自1990年起就设有妇女健康研究办公室。
“That’s a big deal. They’ve been after it for a long time,” he said. “Who the hell wouldn’t have a woman’s health division? Melania said they don’t have it.”
根据该命令,新部门将与该办公室协调运作,而非取代它,并且必须在90天内于NIH的适当研究所或中心成立。
The NIH has an Office of Research on Women’s Health, established in 1990.
白宫表示,此举旨在将政府的关注点从研究扩展到优先将发现转化为妇女和女孩的临床护理。
The new division will operate in coordination with that office rather than replace it, and must be established within an appropriate NIH institute or centre within 90 days, according to the order.
它将重点放在加速诊断和改善研究不足的妇女健康状况的治疗上,提高妇女和女孩在临床试验中的参与度,并要求资助接受者在研究中将性别视为生物变量予以考虑,以确保问责。影响女性比例失调的条件该部门将研究那些独特或不成比例地影响女性的条件,包括心血管疾病、癌症、自身免疫和炎症性疾病、慢性疼痛、子宫内膜异病、子宫肌瘤、多内分泌卵巢综合征、不孕症、更年期、阿尔氏病和骨质疏松症。卫生与公众服务部在一份声明中表示。该命令最早由《今日美国》报道。
The White House said the move is meant to broaden the government’s focus beyond research and prioritise translating discoveries into clinical care for women and girls. It will focus on speeding up diagnosis and improving treatment of women’s health conditions that remain understudied, boosting the inclusion of women and girls in clinical trials, and holding grant recipients accountable for considering sex as a biological variable. Conditions affecting women disproportionately The division will study conditions that uniquely or disproportionately affect women, including cardiovascular disease, cancer, autoimmune and inflammatory conditions, chronic pain, endometriosis, fibroids, polyendocrine metabolic ovary syndrome, infertility, menopause, Alzheimer’s disease and osteoporosis, the Department of Health and Human Services said in a statement. The order was first reported by USA Today.
特朗普将发起该倡议归功于梅拉尼娅·特朗普,她表示该努力应“确保医学突破无论女性经济状况如何都能对女性可及且负担得起”,“用开放的对话、教育和同情心取代几代人的沉默”。特朗普及其政府一直推动医疗削减,包括在国立卫生研究院(NIH),并在2025年缩减联邦医疗人员编制。
Melania Trump, whom Trump credited with conceiving the initiative, said the effort should “ensure that medical breakthroughs are accessible and affordable to women, regardless of their financial circumstances” and “replace generations of silence with open conversation, education and compassion.”Trump and his administration have pushed for healthcare cuts, including at NIH, and in 2025 moved to downsize the federal healthcare workforce.
在特朗普第二任期期间,其政府曾试图削减与多样性相关主题的NIH拨款,据报道正拟允许政治任命人员掌控健康研究资金。
During Trump’s second term, his administration sought to cut NIH grants for research on diversity-related topics and reportedly is moving to allow political appointees to control health-research funding.
该命令撤销了前总统乔·拜登2024年3月的关于推进女性健康研究的行政令,该令由当时的第一夫人吉尔·拜登推动,以及2023年11月的一项备忘录,该备忘录创建了白宫关于该议题的倡议。
The order revokes former President Joe Biden’s March 2024 executive order on advancing women’s health research, which was championed by then-first lady Jill Biden, as well as a November 2023 memorandum that created a White House initiative on the issue.
特朗普政府还启动了堕胎药米佛前列酮的安全审查,这可能为限制铺平道路。
The Trump administration has also launched a safety review of the abortion pill, mifepristone, that could pave the way for restrictions.
主要医学团体批评此举具有政治动机,而反堕胎团体则认为审查进展太慢。今年早些时候,美国官员告诉法院审查将在3月完成。
Major medical groups have criticised the move as politically motivated while anti-abortion groups argue the review is moving too slowly. Earlier in October, US officials told a court the review would be completed by March.
美国卫生官员还从许多激素替代疗法产品中撤除了沿用多年的安全警告,导致供应收紧并引发短缺,同时敦促更多制造商研究可能支持未来女性专用产品审批的 女性睾酮疗法。
US health officials also removed a longstanding safety warning from many hormone replacement therapy products, tightening supplies and leading to shortages, and have urged more manufacturers to study testosterone therapies for women that could support future approvals of female-specific products.
美国卫生与公众服务部(HHS)还针对计划生育资金进行了打击,宣布在2026年初首次要求申请Title X资金的项目必须与特朗普的政治优先事项保持一致,此举引发了法律行动。
HHS has also targeted family planning funds, announcing earlier in 2026 that for the first time it would require applicants for Title X funding to align their programmes with Trump’s political priorities, prompting legal action.